AUA report and update no. 7: April 28, 2009

In an insightful plenary presentation this morning, Dr. Larry Norton offered an explanation of cancer evolution in the individual patient based on the principles of Darwinian evolution and “natural selection .” … READ MORE …

Leonard Salz, MD, on hope and hype

Some regular readers of the cancer literature may want to see an article just published in the Journal of Clinical Oncology by Leonard Salz, MD (a world-famous colorectal cancer specialist) on the way in which language affects perceptions in the world of cancer communication.

The article basically says we all need to be more specific about how we explain things like the difference between “significant” and “statistically significant” or what we mean by “toxicity was tolerable” in a clinical trial. And Dr. Salz makes many good points that The “New” Prostate Cancer InfoLink will do its best to take to heart!

The natural remission of cancer

An article in today’s New York Times, based on an article by Zahl et al. to be published next Tuesday in the Achives of Internal Medicine (but already available on line), is about to stir up a hornets’ nest in the world of cancer research. … READ MORE …

Information about prostate cancer for Central and South Americans

Prostate Cancer International, Inc. is pleased to announce the development of yet another regional web site providing core information about prostate cancer for every country in Central and South America: El Cáncer de Próstata Latinoamérica. … READ MORE …

Thursday’s prostate cancer news: October 23, 2008

In addition to publication of the cryotherapy best practice guidance, other news today includes:

  • Information about selenium levels in blood and prostate tissues
  • An hypothesis about sex steroid-induced inflammatory events as a trigger for prostate cancer development
  • The role of free PSA in diagnosis of prostate cancer in men with a total PSA ≤ 2.5 ng/ml
  • The impact of hormone therapy on strength and musculoskeletal performance … READ MORE …

Results of our first poll: October 16-23, 2008

A total of 91 readers took our first poll (and yes, we had hoped for a few more). The results were  … READ MORE …

Now here’s a shocker for you!

According to an article from HealthDay, published in today’s Washington Post, “Doctors are missing their cues when it comes to opportunities to empathize with the plight of their cancer patients, a new study suggests.” … READ MORE …

Your Sunday prostate cancer news: September 21

The current report covers news from last Thursday through this morning. (Your editor needed a couple of personal days for some quality time!)

  • The FTC has again sought to stop certain companies from making false advertising claims about cancer cures.
  • A new center is to focus on access to prostate cancer screening and partricipation in clinical trials among African-Americans in South Carolina.
  • An “opinion piece” in the International Herald Tribune addresses lifstyle-related issues and cancer risk.
  • A new study provides 2-year data on the use of Fosamax in prevention of bone loss for men under treatment with hormone therapy for prostate cancer. … READ MORE …

New web service for the Caribbean

Effective this morning, Prostate Cancer International is pleased to announce the completion of Phase I of the development of a new web site designed to provide basic, customized information for people in every single Caribbean island nation. For additional information, please visit the Prostate Cancer Caribbean web site

Prostate cancer news update, Thursday, September 11

Today’s prostate cancer update includes information on:

  • The lack of any specific connection between prostate cancer risk and a history of sexually transmitted infection
  • A review of current issues in the management of “high risk” prostate cancer patients
  • The effect the Medicare Modernization Action on the use of orchiectomy as compared to LHRH agonist therapy
  • The impact of prostate cancer treatment and outcomes of treatment on couples … READ MORE …

Fatigue, emotional distress may suggest other problems too

A newly published study reports that, in patients who have been or are being treated for prostate cancer, ”Nurses should be more alert to the possibility of additional treatment-related symptoms when fatigue or emotional distress is present.” Clearly, such a finding is also something patients and their family members or caregivers should be conscious of as well. … READ MORE …

Is a PSM an independent predictor of risk for disease progression?

A study just published by Sæther et al. appears to suggest that the clinical finding of a positive surgical margin (PSM) is not an important independent predictor for risk of progression when compared to other data available at the time of surgery. … READ MORE …

Prostate cancer news update: Tuesday, 9 September

This morning’s news update deals with two newly published studies:

  • The relative effectiveness of two different types of artificial sphincter for the chronically incontinent post-treatment
  • The impact of ADT on metabolic and cardiovascular processes and the risk for significant adverse reactions as a consequence of hypogonadism … READ MORE …

“Entertainment” education about prostate cancer screening

The ability to provide engaging and easily understood information about prostate cancer screening for low literacy popuations is a continuing challenge. Volk et al. have developed and evaluated an “entertainment-based” patient decision aid for prostate cancer screening, comparing its effectiveness among patients with low and high health literacy. … READ MORE …

Tall men and prostate cancer risk … It’s not a certainty

Based on a recent British study, media reports are suggesting that, “Taller men are at greater risk for prostate cancer and more likely to have cancer that progresses quickly.” However, The “New” Prostate Cancer InfoLink suspects that height itself is not the issue. Rather, height may serve as a marker for something biological associated with risk for developing cancer. And even so, this risk is small by comparison with more evident risks such as race, age, and family history. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 828 other followers